EE+ POEM Archive
Limited meta-analysis suggests SGLT2 inhibitors improve cardiovascular outcomes in patients with T2DM + atherosclerosis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Barry, Henry, et al., editors. "Limited Meta-analysis Suggests SGLT2 Inhibitors Improve Cardiovascular Outcomes in Patients With T2DM + Atherosclerosis." EE+ POEM Archive, John Wiley & Sons, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314715/all/Limited_meta_analysis_suggests_SGLT2_inhibitors_improve_cardiovascular_outcomes_in_patients_with_T2DM_+_atherosclerosis.
Limited meta-analysis suggests SGLT2 inhibitors improve cardiovascular outcomes in patients with T2DM + atherosclerosis. In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2019. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314715/all/Limited_meta_analysis_suggests_SGLT2_inhibitors_improve_cardiovascular_outcomes_in_patients_with_T2DM_+_atherosclerosis. Accessed October 3, 2024.
Limited meta-analysis suggests SGLT2 inhibitors improve cardiovascular outcomes in patients with T2DM + atherosclerosis. (2019). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314715/all/Limited_meta_analysis_suggests_SGLT2_inhibitors_improve_cardiovascular_outcomes_in_patients_with_T2DM_+_atherosclerosis
Limited Meta-analysis Suggests SGLT2 Inhibitors Improve Cardiovascular Outcomes in Patients With T2DM + Atherosclerosis [Internet]. In: Barry HH, Ebell MHM, Shaughnessy AFA, Slawson DCD, editors. EE+ POEM Archive. John Wiley & Sons; 2019. [cited 2024 October 03]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314715/all/Limited_meta_analysis_suggests_SGLT2_inhibitors_improve_cardiovascular_outcomes_in_patients_with_T2DM_+_atherosclerosis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Limited meta-analysis suggests SGLT2 inhibitors improve cardiovascular outcomes in patients with T2DM + atherosclerosis
ID - 1314715
ED - Barry,Henry,
ED - Ebell,Mark H,
ED - Shaughnessy,Allen F,
ED - Slawson,David C,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314715/all/Limited_meta_analysis_suggests_SGLT2_inhibitors_improve_cardiovascular_outcomes_in_patients_with_T2DM_+_atherosclerosis
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
